299 related articles for article (PubMed ID: 28805477)
21. Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults.
Stein CR; Ge Y; Wolff MS; Ye X; Calafat AM; Kraus T; Moran TM
Environ Res; 2016 Aug; 149():171-178. PubMed ID: 27208468
[TBL] [Abstract][Full Text] [Related]
22. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
23. Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood.
Pennings JL; Jennen DG; Nygaard UC; Namork E; Haug LS; van Loveren H; Granum B
J Immunotoxicol; 2016; 13(2):173-80. PubMed ID: 25812627
[TBL] [Abstract][Full Text] [Related]
24. Bone mass density following developmental exposures to perfluoroalkyl substances (PFAS): a longitudinal cohort study.
Blomberg A; Mortensen J; Weihe P; Grandjean P
Environ Health; 2022 Nov; 21(1):113. PubMed ID: 36402982
[TBL] [Abstract][Full Text] [Related]
25. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
26. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
27. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
McCusker C; Somerville W; Grey V; Mazer B
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
[TBL] [Abstract][Full Text] [Related]
28. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
Škovránková J; Petráš M
Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
[TBL] [Abstract][Full Text] [Related]
29. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life.
Dannemann A; van Ree R; Kulig M; Bergmann RL; Bauer P; Forster J; Guggenmoos-Holzmann I; Aalberse RC; Wahn U
Int Arch Allergy Immunol; 1996 Nov; 111(3):262-7. PubMed ID: 8917121
[TBL] [Abstract][Full Text] [Related]
30. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines.
West CE; Gothefors L; Granström M; Käyhty H; Hammarström ML; Hernell O
Pediatr Allergy Immunol; 2008 Feb; 19(1):53-60. PubMed ID: 18086218
[TBL] [Abstract][Full Text] [Related]
31. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
Krüger S; Müller-Steinhardt M; Kirchner H; Kreft B
Am J Kidney Dis; 2001 Dec; 38(6):1264-70. PubMed ID: 11728959
[TBL] [Abstract][Full Text] [Related]
32. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children.
Grandjean P; Budtz-Jørgensen E
Environ Health; 2013 Apr; 12(1):35. PubMed ID: 23597293
[TBL] [Abstract][Full Text] [Related]
33. Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood.
Impinen A; Nygaard UC; Lødrup Carlsen KC; Mowinckel P; Carlsen KH; Haug LS; Granum B
Environ Res; 2018 Jan; 160():518-523. PubMed ID: 29106950
[TBL] [Abstract][Full Text] [Related]
34. [Immunity against diphtheria and tetanus in various age groups after 40 years since implementation of the mass vaccination program].
Fordymacka A
Przegl Epidemiol; 2000; 54(3-4):333-41. PubMed ID: 11349596
[TBL] [Abstract][Full Text] [Related]
35. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
[TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
37. Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances.
Timmermann CAG; Budtz-Jørgensen E; Petersen MS; Weihe P; Steuerwald U; Nielsen F; Jensen TK; Grandjean P
Reprod Toxicol; 2017 Mar; 68():164-170. PubMed ID: 27421579
[TBL] [Abstract][Full Text] [Related]
38. Immune response to tetanus booster in infants aged 15 months born prematurely with very low birth weight.
Perin MC; Schlindwein CF; de Moraes-Pinto MI; Simão-Gurge RM; de Mello Almada Mimica AF; Goulart AL; dos Santos AM
Vaccine; 2012 Oct; 30(46):6521-6. PubMed ID: 22959983
[TBL] [Abstract][Full Text] [Related]
39. Humoral immunity against hepatitis B, tetanus, and diphtheria following chemotherapy for hematologic malignancies: a report and review of literature.
Alavi S; Rashidi A; Arzanian MT; Shamsian B; Nourbakhsh K
Pediatr Hematol Oncol; 2010 Apr; 27(3):188-94. PubMed ID: 20367262
[TBL] [Abstract][Full Text] [Related]
40. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.
Pichichero ME; Rennels MB; Edwards KM; Blatter MM; Marshall GS; Bologa M; Wang E; Mills E
JAMA; 2005 Jun; 293(24):3003-11. PubMed ID: 15933223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
